Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: Report of a randomised trial

Mitchell D Creinin, Jill L. Schwartz, Helen C. Pymar, Wendy Fink

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective: To examine the clinical efficacy of mifepristone 600 mg followed on the same day or two days later by misoprostol 400μg orally in women undergoing medical termination of pregnancy whose pregnancies have a gestational age up to 49 days. Design: Prospective, randomised trial. Setting: Clinical research office. Participants: Eighty-six women, requesting elective termination of a pregnancy which has a gestational age of ≤ 49 days. Methods: After administration of mifepristone 600 mg, participants were randomised to take misoprostol six to eight hours later (Group 1) or 48 hours later (Group 2). Women returned for a follow up evaluation 24 ± 1 hours after taking the misoprostol. Participants in Group 1 who had not aborted received a second dose of misoprostol to take 48 hours after the mifepristone. All women returned approximately two weeks after receiving mifepristone. If termination of pregnancy had still not occurred and the pregnancy was non-viable, the woman returned again in three weeks. Main outcome measures: Rate of complete abortion 24 hours after administration of misoprostol. Results: At 24 hours after receiving misoprostol, 21/42 (50%, 95% CI 35%, 65%) women in Group 1 and 40/44 (91%, 95% CI 82%, 99%) women in Group 2 had complete abortions. By follow up two weeks later after the administration of mifepristone, 40/42 (95%, 95% CI 89%, 100%) women in Group 1 and 43/44 (98%, 95% CI 93%, 99%) women in Group 2 were known to have complete abortions. Nausea, vomiting or diarrhoea in women using the standard regimen (Group 2) occurred in 68%, 36%, and 20%, respectively. Conclusions: After treatment with mifepristone 600 mg, administration of misoprostol 400 μg orally on the same day is not as effective at causing abortion within the first 24 hours compared with the standard time interval of 48 hours between medications.

Original languageEnglish (US)
Pages (from-to)469-473
Number of pages5
JournalBritish Journal of Obstetrics and Gynaecology
Volume108
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Misoprostol
Mifepristone
Pregnancy
Gestational Age
Induced Abortion
Nausea
Vomiting
Diarrhea
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy : Report of a randomised trial. / Creinin, Mitchell D; Schwartz, Jill L.; Pymar, Helen C.; Fink, Wendy.

In: British Journal of Obstetrics and Gynaecology, Vol. 108, No. 5, 2001, p. 469-473.

Research output: Contribution to journalArticle

@article{49674e77ab3243c29ab70daea1fe9239,
title = "Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: Report of a randomised trial",
abstract = "Objective: To examine the clinical efficacy of mifepristone 600 mg followed on the same day or two days later by misoprostol 400μg orally in women undergoing medical termination of pregnancy whose pregnancies have a gestational age up to 49 days. Design: Prospective, randomised trial. Setting: Clinical research office. Participants: Eighty-six women, requesting elective termination of a pregnancy which has a gestational age of ≤ 49 days. Methods: After administration of mifepristone 600 mg, participants were randomised to take misoprostol six to eight hours later (Group 1) or 48 hours later (Group 2). Women returned for a follow up evaluation 24 ± 1 hours after taking the misoprostol. Participants in Group 1 who had not aborted received a second dose of misoprostol to take 48 hours after the mifepristone. All women returned approximately two weeks after receiving mifepristone. If termination of pregnancy had still not occurred and the pregnancy was non-viable, the woman returned again in three weeks. Main outcome measures: Rate of complete abortion 24 hours after administration of misoprostol. Results: At 24 hours after receiving misoprostol, 21/42 (50{\%}, 95{\%} CI 35{\%}, 65{\%}) women in Group 1 and 40/44 (91{\%}, 95{\%} CI 82{\%}, 99{\%}) women in Group 2 had complete abortions. By follow up two weeks later after the administration of mifepristone, 40/42 (95{\%}, 95{\%} CI 89{\%}, 100{\%}) women in Group 1 and 43/44 (98{\%}, 95{\%} CI 93{\%}, 99{\%}) women in Group 2 were known to have complete abortions. Nausea, vomiting or diarrhoea in women using the standard regimen (Group 2) occurred in 68{\%}, 36{\%}, and 20{\%}, respectively. Conclusions: After treatment with mifepristone 600 mg, administration of misoprostol 400 μg orally on the same day is not as effective at causing abortion within the first 24 hours compared with the standard time interval of 48 hours between medications.",
author = "Creinin, {Mitchell D} and Schwartz, {Jill L.} and Pymar, {Helen C.} and Wendy Fink",
year = "2001",
doi = "10.1016/S0306-5456(00)00117-0",
language = "English (US)",
volume = "108",
pages = "469--473",
journal = "BJOG: An International Journal of Obstetrics and Gynaecology",
issn = "1470-0328",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy

T2 - Report of a randomised trial

AU - Creinin, Mitchell D

AU - Schwartz, Jill L.

AU - Pymar, Helen C.

AU - Fink, Wendy

PY - 2001

Y1 - 2001

N2 - Objective: To examine the clinical efficacy of mifepristone 600 mg followed on the same day or two days later by misoprostol 400μg orally in women undergoing medical termination of pregnancy whose pregnancies have a gestational age up to 49 days. Design: Prospective, randomised trial. Setting: Clinical research office. Participants: Eighty-six women, requesting elective termination of a pregnancy which has a gestational age of ≤ 49 days. Methods: After administration of mifepristone 600 mg, participants were randomised to take misoprostol six to eight hours later (Group 1) or 48 hours later (Group 2). Women returned for a follow up evaluation 24 ± 1 hours after taking the misoprostol. Participants in Group 1 who had not aborted received a second dose of misoprostol to take 48 hours after the mifepristone. All women returned approximately two weeks after receiving mifepristone. If termination of pregnancy had still not occurred and the pregnancy was non-viable, the woman returned again in three weeks. Main outcome measures: Rate of complete abortion 24 hours after administration of misoprostol. Results: At 24 hours after receiving misoprostol, 21/42 (50%, 95% CI 35%, 65%) women in Group 1 and 40/44 (91%, 95% CI 82%, 99%) women in Group 2 had complete abortions. By follow up two weeks later after the administration of mifepristone, 40/42 (95%, 95% CI 89%, 100%) women in Group 1 and 43/44 (98%, 95% CI 93%, 99%) women in Group 2 were known to have complete abortions. Nausea, vomiting or diarrhoea in women using the standard regimen (Group 2) occurred in 68%, 36%, and 20%, respectively. Conclusions: After treatment with mifepristone 600 mg, administration of misoprostol 400 μg orally on the same day is not as effective at causing abortion within the first 24 hours compared with the standard time interval of 48 hours between medications.

AB - Objective: To examine the clinical efficacy of mifepristone 600 mg followed on the same day or two days later by misoprostol 400μg orally in women undergoing medical termination of pregnancy whose pregnancies have a gestational age up to 49 days. Design: Prospective, randomised trial. Setting: Clinical research office. Participants: Eighty-six women, requesting elective termination of a pregnancy which has a gestational age of ≤ 49 days. Methods: After administration of mifepristone 600 mg, participants were randomised to take misoprostol six to eight hours later (Group 1) or 48 hours later (Group 2). Women returned for a follow up evaluation 24 ± 1 hours after taking the misoprostol. Participants in Group 1 who had not aborted received a second dose of misoprostol to take 48 hours after the mifepristone. All women returned approximately two weeks after receiving mifepristone. If termination of pregnancy had still not occurred and the pregnancy was non-viable, the woman returned again in three weeks. Main outcome measures: Rate of complete abortion 24 hours after administration of misoprostol. Results: At 24 hours after receiving misoprostol, 21/42 (50%, 95% CI 35%, 65%) women in Group 1 and 40/44 (91%, 95% CI 82%, 99%) women in Group 2 had complete abortions. By follow up two weeks later after the administration of mifepristone, 40/42 (95%, 95% CI 89%, 100%) women in Group 1 and 43/44 (98%, 95% CI 93%, 99%) women in Group 2 were known to have complete abortions. Nausea, vomiting or diarrhoea in women using the standard regimen (Group 2) occurred in 68%, 36%, and 20%, respectively. Conclusions: After treatment with mifepristone 600 mg, administration of misoprostol 400 μg orally on the same day is not as effective at causing abortion within the first 24 hours compared with the standard time interval of 48 hours between medications.

UR - http://www.scopus.com/inward/record.url?scp=0034968119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034968119&partnerID=8YFLogxK

U2 - 10.1016/S0306-5456(00)00117-0

DO - 10.1016/S0306-5456(00)00117-0

M3 - Article

C2 - 11368131

AN - SCOPUS:0034968119

VL - 108

SP - 469

EP - 473

JO - BJOG: An International Journal of Obstetrics and Gynaecology

JF - BJOG: An International Journal of Obstetrics and Gynaecology

SN - 1470-0328

IS - 5

ER -